Leading Italian pharmaceutical companies 2021, by revenue

In 2021, Pfizer S.r.l. was the leading Italian pharmaceutical company, with an annual revenue of approximately 1.8 billion euros. Chiesi and Sanofi came second and third in the ranking, both with revenue of 1.4 billion euros. According to the the data provided by Competitive Data, closing the ranking of the five largest Italian pharmaceutical firms was Janssen Cilag with a revenue of 1.1billion euros. Italian pharmaceutical industry In 2022, Italy accounted for 2.4 percent of the global pharmaceutical sales, ranking sixth among the top ten pharmaceutical markets worldwide. The production value of the Italian pharmaceutical industry grew steadily over time, peaking in 2023 at 52 billion euros.   Pharmaceutical trade  The share of Italian pharmaceutical products exported abroad grew remarkably. During the twenty-year period from 1997 to 2019, the percentage of production exported grew from 34 to 96 percent. In 2021, Belgium and the United States were the leading destination countries for the Italian pharmaceutical preparations.

于2021年，Pfizer S.r.l. 悉数领跑于意大利制药行业，年营业额高达约18亿欧元。Chiesi 与 Sanofi 分别位居第二及第三，两者营业额均为14亿欧元。根据Competitive Data提供的数据，在意大利最大的五家制药企业排名中，位列第五的是Janssen Cilag，其营业额约为11亿欧元。在意大利制药产业中，2022年意大利占全球药品销售额的2.4%，在全球十大药品市场排名中位列第六。意大利制药产业的产值随时间稳步增长，于2023年达到峰值，达到520亿欧元。在药品贸易方面，意大利药品出口份额显著增长。在1997年至2019年的二十年间，出口产量的百分比从34%增长至96%。在2021年，比利时和美国是意大利药品制剂的主要出口目的地。